3H Corporate History
Our Journey Since 2005
2005
February
Clinical Trial Co., Ltd. (a limited liability company at the time) was established. Started recruiting healthy volunteers for clinical trials. Launched the mobile website “e-chiken Mobile” for healthy volunteer trial information.
August
Began recruiting patients for disease-specific trials, health food studies, and cosmetic trials. Launched the PC-based trial information site “U”.
2006
June
“e-Clinical Trial Mobile” was renewed and renamed to “Seikatsu Kojo Mobile”. Reorganized as Clinical Trial Co., Ltd. (a corporation).
2008
March
“U” was relaunched as “Seikatsu Kojo WEB”.
2009
March
Established CROèe Co., Ltd., a CRO specializing in patient recruitment.
June
Clinical Trial Co., Ltd. obtained Privacy Mark certification and ISO/IEC 27001:2005, JIS Q 27001:2006. CROèe joined the clinical development support network cooperative “SMONA”.
2010
March
Clinical Trial Co., Ltd. opened the Osaka office and partnered with the clinical trial specialty clinic “Tokyo Center Clinic”.
2014
FebruaryOpened the Fukuoka office.
MarchEstablished SMO CTS Co., Ltd.
JulyCROèe obtained ISO/IEC 27001 certification. Established U.S. subsidiary CROèe US INC.
2015
FebruaryEstablished Asia’s first patient recruitment network “APRO”.
MarchLaunched Japan’s first clinical trial search app “Seikatsu Kojo App” (Android & iOS).
MayOpened oncology-focused web portal “Oncolo”.
2016
January“Seikatsu Kojo WEB” began information collaboration with Yahoo! Healthcare.
AprilLaunched rental service for trial-use mobile device “cPhone”, pediatric trial support app, and “Patient Insight Pack”.
JulyBuilt strategic collaboration with EPS Co., Ltd. for subject recruitment.
AugustBegan offering white papers summarizing subject recruitment information.
SeptemberLaunched “Orphan Disease Recruitment Quick Package”.
October“Oncolo” collaborated with “INTELLIM”.
December“Oncolo” and AstraZeneca conducted lung cancer retesting study.
2017
September“Oncolo” and National Cancer Center Hospital launched rare cancer seminar “Meet the Expert”.
OctoberLaunched rare disease information site “RareS.”
2018
JanuaryLaunched “Osaka Oncology Seminar” and senior health community “Seikatsu Kojo Club”.
MarchLaunched new communication channel via “Pharmacy Network”.
MayLaunched cancer consultation service “Oncole”.
OctoberLaunched global health tech news site “Connect Health”.
NovemberLaunched IT Healthcare program with University of Tokyo and Neopharma Japan. Established 3H Life Science Institute.
2019
FebruaryRareS. co-hosted Rare Disease Day event with University of Tokyo.
AprilTransitioned to holding company structure with 3H Holdings.
MayLaunched Patient-Centric Rare Disease R&D Program with University of Tokyo.
AugustOpened new clinical trial center in Miyazaki.
NovemberPartnership formed with A2 Healthcare to promote patient engagement.
2020
AprilLaunched ePRO system “3H P-Guardian”.
JulyLaunched hybrid-style virtual clinical research.
SeptemberDeveloped follow-up system for gene therapy patients.
OctoberLaunched “All About Stomach Cancer” video series.
2021
JanuaryEstablished joint venture “Four H” with HYPER CUBE.
MarchOncolo published book “A Guide to Optimal Cancer Treatment for You”.
OctoberPartnered with Science 37® to enable Decentralized Clinical Trials.
2022
February
Joined the M3 Group.